Skip to content

Vacuum-Assisted Dressings (V-AD) in the Management of Open Chest Wounds

A Pilot Study to Evaluate the Efficacy of Vacuum-Assisted Dressings (V-AD) in the Management of Open Chest Wounds

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02803164
Enrollment
21
Registered
2016-06-16
Start date
2017-02-10
Completion date
2020-11-03
Last updated
2021-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Open Chest Wounds

Brief summary

Vacuum-assisted dressings (V-AD) are effective in treating patients with open chest wounds (OCW) and will decrease the time-to-closure of such wounds when compared to a historical cohort of patients managed by traditional wound care management.

Interventions

DEVICEWound Vacuum-assisted dressing

The NPWT system (V.A.C. Therapy System, KCI USA Inc.) consisted of a medical-grade non-adherent polyvinyl alcohol white foam applied directly to the infected surface, followed by an open-pore reticulated polyurethane black foam cut to fit the wound and covered by a transparent air-tight adhesive drape. A suction cup with tubing was placed over a small slit on the drape and connected to a suction machine (V.A.C. ULTA Therapy Unit).

OTHERControl group

Retrospective review of subjects medical records with open chest wounds who were treated with the traditional treatment techniques.

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject is scheduled to undergo surgical intervention(s) as part of the standard care for management of intra-thoracic infection.

Exclusion criteria

* Patent bronchopleural fistulas. Severe respiratory failure requiring mechanical ventilation at the time of first consultation. * Proven or suspected malignancy in the wound. Coagulopathy due to medical or pharmacologic reasons. Dependency on anticoagulants or antiplatelet medication due to high risk for adverse events if these medications are stopped for a prolonged period of time. Allergy to acrylic products.

Design outcomes

Primary

MeasureTime frameDescription
Duration of Negative Pressure Wound Therapy (NWPT)12 month follow upThe total number of days of receiving NWPT

Secondary

MeasureTime frameDescription
Wound Closure12 monthsThe total number of days to wound closure
Length of Hospital Stay12 monthsThe total number of days in hospital

Countries

United States

Participant flow

Participants by arm

ArmCount
Intervention
Treatment of wound with Vacuum-assisted dressing. Wound Vacuum-assisted dressing: Management of chronic open chest wounds with V-AD assisted dressing.
10
Control Group
Historical chest wound treatment.
11
Total21

Baseline characteristics

CharacteristicControl GroupTotalIntervention
Age, Continuous62 years62 years61 years
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
11 participants21 participants10 participants
Sex: Female, Male
Female
1 Participants8 Participants7 Participants
Sex: Female, Male
Male
10 Participants13 Participants3 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
2 / 101 / 11
other
Total, other adverse events
2 / 108 / 11
serious
Total, serious adverse events
2 / 1011 / 11

Outcome results

Primary

Duration of Negative Pressure Wound Therapy (NWPT)

The total number of days of receiving NWPT

Time frame: 12 month follow up

Population: Data not collected or analyzed for the Historical Control arm. This arm did not receive the NWPT.

ArmMeasureValue (MEDIAN)
InterventionDuration of Negative Pressure Wound Therapy (NWPT)8 Days
Secondary

Length of Hospital Stay

The total number of days in hospital

Time frame: 12 months

ArmMeasureValue (MEDIAN)
InterventionLength of Hospital Stay6 Days
Historical ControlLength of Hospital Stay25 Days
Secondary

Wound Closure

The total number of days to wound closure

Time frame: 12 months

ArmMeasureValue (MEDIAN)
InterventionWound Closure7 Days
Historical ControlWound Closure18 Days

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026